Pharmacokinetics & Relative Bioavailability Study

Clinical Trial Description

Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06201013` - Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children	N/A
Recruiting	`NCT05880862` - Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls	Early Phase 1
Recruiting	`NCT04807920` - BOTOX® at the Time of Prolapse Surgery for OAB	Phase 4
Terminated	`NCT02385500` - Fesoterodine on Urgency Episodes in Parkinson's Disease Population	Phase 4
Not yet recruiting	`NCT02477241` - Brain Areas Involved in Bladder Filling and Contraction	N/A
Completed	`NCT01698138` - Prevention of Bladder Dysfunction in Acute Spinal Cord Injury	Phase 4
Completed	`NCT00613327` - An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants	Phase 4
Completed	`NCT00527033` - A Study of YM178 in Patients With Symptomatic Overactive Bladder	Phase 2
Completed	`NCT00368706` - A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients	Phase 3
Recruiting	`NCT04305743` - Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A	Phase 4
Active, not recruiting	`NCT03681678` - Laser Therapy for Treatment of Urogenital Symptoms in Women
Completed	`NCT01655069` - A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076	Phase 3
Completed	`NCT01558856` - Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder	N/A
Completed	`NCT01157377` - Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence	Phase 2
Completed	`NCT01381120` - Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms	Phase 4
Completed	`NCT01194999` - Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence	Phase 4
Completed	`NCT01262391` - Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents	Phase 1
Completed	`NCT04528784` - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis	N/A
Completed	`NCT02849418` - Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity	Phase 3
Recruiting	`NCT05968885` - Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity	Phase 4

NCT number	NCT01521767
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	October 2011
Completion date	November 2011

Pharmacokinetics and Relative Bioavailability Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms